References
- Balasar, M., & Cicekci, F. (2016). Oxybutynin addiction amongst prisoners: Two case reports/Mahkumlar arasinda oxibutinin bagimliligi: Iki olgu sunumu. Anadolu Psikiyatri Dergisi, 17(3), 77. https://doi.org/10.5455/apd.172823
- Buhrich, N., Weller, A., & Kevans, P. (2000). Misuse of anticholinergic drugsby people with serious mental illness. Psychiatric Services, 51(7), 928–929. https://doi.org/10.1176/appi.ps.51.7.928
- Çoban, Ö. G., Tulacı, Ö. D., & Adanır, A. S. (2019). Oxybutynin addiction of 3 cases. Klinik Psikofarmakoloji Bulteni, ek S1, Istanbul, 29(2019), 147.
- Ferrara, P., d’Aleo, C., Tarquini, E., Salvatore, S., & Salvaggio, E. (2001). Side‐effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU International, 87(7), 674–678. https://doi.org/10.1046/j.1464-410x.2001.02152.x
- Hadidi, K. A. (2004). Development of a screening method for the most commonly abused anticholinergic drugs in Jordan; trihexyphenidyl, procyclidine and biperiden. Legal Medicine, 6(4), 233–241. https://doi.org/10.1016/j.legalmed.2004.06.001
- Jirschele, K., & Sand, P. K. (2013). Oxybutynin: Past, present, and future. International Urogynecology Journal, 24(4), 595–604. https://doi.org/10.1007/s00192-012-1915-8
- Kardas, O., & Kardas, B. (2019). THE OXYBUTYNIN ABUSE IN ADOLESCENT CASE. SANAMED, 14(1), 91–94. https://doi.org/10.24125/sanamed.v14i1.300
- Kınık, M., Dönder, F., Duymaz, M., & Karakaya, I. (2015). Addiction of oxybutynin: an adolescent case report. Journal of Addiction Research and Therapy, 6(228), 2. http://doi.org/10.4172/2155-6105.1000228
- Marken, P. A., Stoner, S. C., & Bunker, M. T. (1996). Anticholinergic drug abuse and misuse. CNS Drugs, 5(3), 190–199. https://doi.org/10.2165/00023210-199605030-00005
- Pierce, R. C., & Kumaresan, V. (2006). The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neuroscience and Biobehavioral Reviews, 30(2), 215–238. https://doi.org/10.1016/j.neubiorev.2005.04.016
- U.S. Department of Health & Human Services. (2020, September). FDA Pregnancy Categories. U.S. Department of Health & Human Services, National Institutes of Health. https://chemm.nlm.nih.gov/pregnancycategories.htm